International Journal of Research in Pharmacy and Allied Science

ISSN: 2583-6544   |  Issues per year: Monthly  |   Indexed In: Google Scholar, CORE, ScienceOpen, Researchgate

ISSN:2583-6544

Abstract View

Design and Implementation of a Digital Pharmacovigilance Support Platform: Interaction Detection, ADR Monitoring, and Reporting

Author(s): Mujahid Ahmed Haroon Rasheed1

Email(s): 1mujahidpharm22@gmail.com

Address:

    JMCT Institute of Pharmacy, Khode Nagar, Tirumla Nagar, Kalpataru Nagar, Nashik, Maharashtra

Published In:   Volume - 4,      Issue - 10,     Year - 2025

DOI: https://doi.org/10.71431/IJRPAS.2025.41007  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Adverse drug reactions (ADRs) and drug–drug interactions (DDIs) remain critical challenges in clinical practice, often leading to preventable morbidity and mortality. Limited access to reliable drug information and under-reporting of ADRs further compromise patient safety. Recent studies highlight the potential of mobile and web-based applications to improve real-time pharmacovigilance, enhance data completeness, and increase awareness among healthcare professionals and patients (SpringerLink; BioMed Central). In this context, MediSafe was designed and developed as an integrated digital platform to address these challenges by combining multiple pharmacological utilities in a single responsive application. The system consists of five modules: (a) a DDI Checker to detect potential interactions between multiple drugs; (b) an ADR Prediction tool that lists possible adverse effects and warnings; (c) an ADR Reporting interface allowing users to record suspected ADRs with structured input; and (e) a View Reports section that, mobile app deployment, and large-scale clinical evaluation.

Keywords:

Cite this article:
Mujahid Ahmed Haroon Rasheed. Design and Implementation of a Digital Pharmacovigilance Support Platform: Interaction Detection, ADR Monitoring, and Reporting. IJRPAS, October 2025; 4(10): 96-112.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.41007


1.      Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso—shows increased reporting after implementing mobile-based ADR tools. SpringerLink

2.      Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience – impact and lessons of ADR apps globally. SpringerLink

3.      Effectiveness of mobile applications in enhancing adverse drug reaction reporting: a systematic review – compares reporting rates, completeness, and user engagement. BioMed Central

4.       Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. PubMed

5.        A meta-analysis assessing the prevalence of drug-drug interactions among hospitalized patients. PubMed

6.        Prevalence of drug–drug interactions in geriatric patients at an ambulatory care pharmacy in a tertiary care teaching hospital. BioMed Central

7.        Drug-drug interactions among hospitalized elderly patients in Northwest Ethiopia: observational study. SAGE Journals

8.        A study on drug-drug interactions through prescription analysis in a South Indian teaching hospital. PubMed

9.        Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: systematic review & meta-analysis. PubMed

10.    Drug-drug interaction among elderly patients in Africa: systematic review and meta-analysis. BioMed Central

11.    The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan. PMC

12.    Drug information-seeking behaviours of physicians, nurses and pharmacists: systematic review. PubMed

13.    Harnessing scientific literature reports for pharmacovigilance: prototype tool development & usability testing. PubMed

14.    Modeling polypharmacy side effects with graph convolutional networks. arXiv

15.    Predicting rich drug-drug interactions via biomedical knowledge graphs. arXiv

16.    CASTER: Predicting drug interactions with chemical substructure representation. arXiv

17.    Assessment of drug-drug interactions in the prescription of elderly patients on cardiovascular drugs. IJBC Pharmacology+1

18.    Clinical assessment and management of drug-drug interactions in hypertensive patients with comorbidities. jpbs.in+1

19.  Next.js — Architecture & Docs. Next.js

20.  Next.js — Server-Side Rendering documentation. Next.js

21.  Next.js — Building APIs with Next.js (blog). Next.js

22.  Strapi blog — SSR vs SSG in Next.js (guidance on rendering strategies). Strapi

23.  Tailwind CSS — benefits and real-world usage (Grid Dynamics blog). Grid Dynamics

24.  IJRPR — Tailwind CSS research article (utility-first evaluation). IJRPR

25.  shadcn/ui — docs & Next.js integration. Shadcn UI+1

26.  Lucide / lucide-react (icon library docs). Lucide+1

27.  MDN — Using Mongoose with Node.js (tutorial). MDN Web Docs

28.  Mongoose ODM — best practices and patterns (dev.to / Medium articles). DEV Community+1

29.  MongoDB — healthcare & AI use cases (MongoDB blog). MongoDB

30.  Performance analysis / benchmarking of NoSQL DBs for healthcare (research article). ResearchGate

31.  Clean architecture patterns with Node.js, Mongoose & MongoDB (tutorial). Medium

32.  MERN Stack review (impact and practical considerations). ijgst.com

33.  Practical guide: API Routes & patterns in Next.js (community tutorial). Medium

34.    Hammar, T. et al. (2021). Current Knowledge about Providing Drug–Drug Interaction Information through Mobile Applications. PubMed Central. PMC

35.    Fukushima, A. et al. (2022). Smartphone-based mobile applications for adverse drug reaction reporting: A systematic review. PubMed Central. PMC

36.    Hyzy, M. et al. (2022). System Usability Scale Benchmarking for Digital Health Apps. JMIR mHealth and uHealth. JMIR mHealth and uHealth

37.    Parracha, E. R. et al. (2022). Mobile apps for quick adverse drug reaction report. PubMed Central. PMC

38.    Hyzy, M. et al. (2022). System Usability Scale Benchmarking for Digital Health Apps. PubMed Central. PMC

39.    Dedefo, M. G. (2025). Completeness of spontaneously reported adverse drug reactions: A comparative study. Wiley Online Library. BPS Publications

40.   Leskur, D. (2022). Adverse drug reaction reporting via mobile applications. ScienceDirect. ScienceDirect

41.    Dubale, A. T. et al. (2024). Healthcare professionals' willingness to utilize a mobile health application for ADR reporting. ScienceDirect. ScienceDirect

42.    Kim, B. Y. B. et al. (2018). Consumer Mobile Apps for Potential Drug-Drug Interaction Checking: A Systematic Review. PubMed Central. PMC

43.    Parracha, E. R. et al. (2023). Mobile apps for quick adverse drug reaction report: A systematic review. Wiley Online Library. Wiley Online Library

44.    Wells, C. (2022). An Overview of Smartphone Apps in Healthcare. National Center for Biotechnology Information. NCBI

45.    Busari, A. (2024). Assessing the Impact of Usability from Evaluating Mobile Health Applications. Skeena Publishers. Skeena Publishers | Open Access Journals

46.    Zhou, L. et al. (2019). The mHealth App Usability Questionnaire (MAUQ): Development and Validation. JMIR mHealth and uHealth. JMIR mHealth and uHealth

47.    García-Sánchez, S. et al. (2022). Mobile Health Apps Providing Information on Drugs for Adult Emergency Professionals. JMIR mHealth and uHealth. JMIR mHealth and uHealth

48.    Domián, B. M. et al. (2025). Comparative evaluation of artificial intelligence platforms for drug interaction prediction. ScienceDirect. ScienceDirect

49.    Leskur, D. (2022). Adverse drug reaction reporting via mobile applications. ScienceDirect. ScienceDirect

50.    Parracha, E. R. et al. (2022). Mobile apps for quick adverse drug reaction report. PubMed Central. PMC

51.    Hyzy, M. et al. (2022). System Usability Scale Benchmarking for Digital Health Apps. PubMed Central. PMC

52.    Dedefo, M. G. (2025). Completeness of spontaneously reported adverse drug reactions: A comparative study. Wiley Online Library. BPS Publications

53.    Hyzy, M. et al. (2022). System Usability Scale Benchmarking for Digital Health Apps. PubMed Central. JMIR mHealth and uHealth

54.    Current Knowledge about Providing Drug–Drug Interaction Services (scoping review) — discusses challenges, accuracy, coverage of DDI tools. PMC

55.   Content and Usability Evaluation of Patient Oriented Drug-Drug Interaction Website — evaluates correctness and usability of DDI tools. PMC

56.    Effectiveness of Mobile Applications in Enhancing Adverse Drug Reaction Reporting — compares ADR report quality via apps vs traditional methods. BioMed Central

57.    Evaluation of the Med Safety Mobile App for Reporting Adverse Events in Burkina Faso — a real implementation and evaluation of ADR reporting via app. SpringerLink

58.    Design and Development of a Mobile Application for Medication Information (Agudelo et al., 2025) — example of similar app with information modules. ScienceDirect

59.    Application of Artificial Intelligence in Drug–Drug Interactions — review of predictive models and data sources used for DDI prediction. ACS Publications

60.    Artificial Intelligence-Driven Drug Interaction Prediction — discusses ML/AI approaches for interaction sensitivity/specificity. ResearchGate

61.    Factors Influencing the Use of a Mobile App for ADR Reporting — qualitative study on adoption, usability, barriers/facilitators. PubMed

62.    Adverse Drug Reaction Reporting via Mobile Applications: A Narrative Review — summary of ADR apps, advantages, limitations. ResearchGate

63.    A Web-Based Tool to Report Adverse Drug Reactions — usability evaluation of web ADR reporting systems. Formative

64.   A Mobile App Leveraging Citizen Engagement for ADR Reporting — describes usability and features related to ADR apps. Human Factors

65.   Regulators Move Toward ADR Reporting via Mobile Apps — overview of policy trends and adoption in pharmacovigilance. ResearchGate

66.    Qualitative Study Using Task-Technology Fit Framework for ADR Reporting by Community Pharmacists — barriers/facilitators and design needs. I-JMR

67.   Consumer Views on the Use of Digital Tools for Reporting ADRs — analysis of uptake, user experience, reporting changes. PMC

68.   Evaluation of the Performance of DDI Screening Software in Pharmacies — a benchmark study of DDI detection in pharmacy systems. ResearchGate

 

Related Images:



Recent Images



Neurological Complications among Pregnant and Post Partum Mothers in a Private Hospital, Yogyakarta, Indonesia
Review on Regulatory Affairs in Pharmaceutical Industry
Cucumber and Mint Soap: Preparation and Evaluation
Topical Delivery in Cosmetics: Enhancing Penetration and Bioavailability
Formulation and Evaluation of Polyherbal Soap
Gelatin: A Widely Used Pharmaceutical Excipient
Therapeutic insights into Saroglitazar: a dual PPAR- α/γ agonist targeting diabetic dyslipidaemia and NAFLD
A Comprehensive Review on Dyslipidemia and Obesity: Pathophysiology, Clinical Implications and Management Approaches
Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview
Review on Clinical Research and Clinical Trials

Tags


Quick Links


Latest Issues

Popular Articles